Top 5 Most-Read IVBM Content of 2025

Clinicians, health system leaders, payers, and pharmacists across the country have convened at several Institute for Value-Based Medicine (IVBM) events throughout 2025 to examine how value-based care is evolving in practice. From advanced cell therapies to integrated population health and cardio-kidney-metabolic (CKM) disease management, these discussions focused on aligning novel care with affordability, access, and patient-centered outcomes.

Here are the top IVBM articles from 2025 capturing how value-based strategies are translating into real-world impact. Click here to learn more about The American Journal of Managed Care^® (AJMC^®) IVBM events, read past coverage, and find an upcoming event near you.

5. Value-Based Care Calls for Putting Novel Therapies Closer to Patients

Leaders in oncology care met in Princeton, New Jersey, to discuss how value-based models can improve access, outcomes, and affordability by bringing advanced therapies and clinical trials closer to patients’ homes. Experts also focused on optimizing the delivery of chimeric antigen receptor T-cell and bispecific therapies, highlighting how collaboration between academic centers and community practices can expand access while managing toxicity and cost. Clinicians and pharmacists talked about how team-based care, patient navigation, and streamlined protocols are essential to sustainably delivering high-cost innovations in lymphoma and multiple myeloma care.

Read the article.

4. Experts Issue a Call to Action for Oncology Care Equity

Oncology leaders in Nashville, Tennessee, issued a call to action to advance health equity by addressing social determinants of health, insurance design barriers, and site-of-care restrictions that limit access to high-quality cancer care. Discussions emphasized that academic-community partnerships, standardized care pathways, and multidisciplinary collaboration are essential to expanding access to advanced therapies, clinical trials, and precision medicine. Across panels on equity, precision oncology, and pharmacy-led care delivery, speakers highlighted trust-building, patient navigation, and coordinated care transitions as central to delivering equitable, value-based oncology care.

Read the article.

3. Population Health Reimagined Through Integrated Care

At an IVBM meeting in New Orleans, Louisiana, health system, academic, and payer leaders shared updates on Ochsner Health’s Healthy State initiative and its integrated-care approach to improving population health. Speakers highlighted measurable gains in smoking cessation, education, and cancer screening while emphasizing that sustained progress depends on addressing social determinants of health, strengthening the health care workforce, and fostering cross-sector partnerships. Discussions underscored that trust, data-driven coordination, and patient-centered integrated care models are essential to advancing value-based care in a state facing persistent health disparities.

Read the article.

2. Reducing Care Fragmentation to Boost CKM Disease Outcomes

At an IVBM event held in partnership with UPMC in Pittsburgh, Pennsylvania, clinicians, health plan leaders, and researchers examined how integrated, multidisciplinary care models can reduce fragmentation and improve outcomes across CKM disease. Speakers highlighted data-driven population health strategies—proactive e-consults, telemedicine clinics, and pharmacist-supported medication optimization—that lowered hemoglobin A_1c, reduced hospitalizations, and improved guideline-directed therapy uptake in patients with diabetes, heart failure, and chronic kidney disease. Panelists stressed that breaking down specialty silos will be key to slowing disease progression, easing financial toxicity, and helping primary care teams manage CKM disease more effectively over time.

Read the article.

1. Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most

At a Dallas, Texas, IVBM event, leaders in cardiology discussed how value-based care can guide the adoption of new diagnostics, therapies, and care models across the full continuum, from prevention and risk stratification to heart failure management and rehabilitation. Speakers highlighted practical strategies such as primary care provider–driven algorithms for chest pain evaluation, biomarker-guided prevention in diabetes, targeted use of remote patient monitoring, and rethinking access to cardiac rehabilitation to improve outcomes while controlling costs. The discussions underscored that aligning advanced cardiology tools with patient goals, social context, and efficient care pathways is essential to ensuring innovations reach the patients most likely to benefit.

Read the article.